TCS 1102 |
A dual antagonist of both OX1R and OX2R (Kis = 0.2 and 3 nM, respectively)… |
10 mg |
18495-10 |
More Info
|
TCS 1102 |
A dual antagonist of both OX1R and OX2R (Kis = 0.2 and 3 nM, respectively)… |
25 mg |
18495-25 |
More Info
|
TCS 1102 |
A dual antagonist of both OX1R and OX2R (Kis = 0.2 and 3 nM, respectively)… |
5 mg |
18495-5 |
More Info
|
TCS 21311 |
A JAK3 inhibitor (IC50 = 8 nM); selective for JAK3 over JAK1, JAK2, and TY… |
1 mg |
30063-1 |
More Info
|
TCS 21311 |
A JAK3 inhibitor (IC50 = 8 nM); selective for JAK3 over JAK1, JAK2, and TY… |
10 mg |
30063-10 |
More Info
|
TCS 21311 |
A JAK3 inhibitor (IC50 = 8 nM); selective for JAK3 over JAK1, JAK2, and TY… |
25 mg |
30063-25 |
More Info
|
TCS 21311 |
A JAK3 inhibitor (IC50 = 8 nM); selective for JAK3 over JAK1, JAK2, and TY… |
5 mg |
30063-5 |
More Info
|
TCS 2210 |
A small molecule inducer of neuronal differentiation; increases expression… |
1 mg |
16142-1 |
More Info
|
TCS 2210 |
A small molecule inducer of neuronal differentiation; increases expression… |
5 mg |
16142-5 |
More Info
|
TCS 2210 |
A small molecule inducer of neuronal differentiation; increases expression… |
500 µg |
16142-500 |
More Info
|
TCS 401 |
A selective inhibitor of PTP1B (Ki = 0.29 µM) |
1 mg |
20393-1 |
More Info
|
TCS 401 |
A selective inhibitor of PTP1B (Ki = 0.29 µM) |
10 mg |
20393-10 |
More Info
|
TCS 401 |
A selective inhibitor of PTP1B (Ki = 0.29 µM) |
25 mg |
20393-25 |
More Info
|
TCS 401 |
A selective inhibitor of PTP1B (Ki = 0.29 µM) |
5 mg |
20393-5 |
More Info
|
TCS 5861528 |
A selective TRPA1 blocker that antagonizes TRPA1-mediated calcium influx i… |
10 mg |
18380-10 |
More Info
|
TCS 5861528 |
A selective TRPA1 blocker that antagonizes TRPA1-mediated calcium influx i… |
25 mg |
18380-25 |
More Info
|
TCS 5861528 |
A selective TRPA1 blocker that antagonizes TRPA1-mediated calcium influx i… |
5 mg |
18380-5 |
More Info
|
TCS 5861528 |
A selective TRPA1 blocker that antagonizes TRPA1-mediated calcium influx i… |
50 mg |
18380-50 |
More Info
|
TC-S 7001 |
A ROCK inhibitor (IC50s = 0.6 and 1.1 nM, respectively, for human ROCK1 an… |
1 mg |
19129-1 |
More Info
|
TC-S 7001 |
A ROCK inhibitor (IC50s = 0.6 and 1.1 nM, respectively, for human ROCK1 an… |
5 mg |
19129-5 |
More Info
|
TC-S 7001 |
A ROCK inhibitor (IC50s = 0.6 and 1.1 nM, respectively, for human ROCK1 an… |
500 µg |
19129-500 |
More Info
|
TCS ERK 11e |
A selective inhibitor of ERK2 (Ki 50 = 48 nM) |
1 mg |
19932-1 |
More Info
|
TCS ERK 11e |
A selective inhibitor of ERK2 (Ki 50 = 48 nM) |
10 mg |
19932-10 |
More Info
|
TCS ERK 11e |
A selective inhibitor of ERK2 (Ki 50 = 48 nM) |
25 mg |
19932-25 |
More Info
|
TCS ERK 11e |
A selective inhibitor of ERK2 (Ki 50 = 48 nM) |
5 mg |
19932-5 |
More Info
|
TCS HDAC6 20b |
An HDAC6 inhibitor; inhibits the growth of HCT116 cells when used at a con… |
1 mg |
14977-1 |
More Info
|
TCS HDAC6 20b |
An HDAC6 inhibitor; inhibits the growth of HCT116 cells when used at a con… |
5 mg |
14977-5 |
More Info
|
TCS-OX2-29 |
An antagonist of OX2R (pKi = 7.5) that exhibits >250-fold selectivity for… |
10 mg |
17419-10 |
More Info
|
TCS-OX2-29 |
An antagonist of OX2R (pKi = 7.5) that exhibits >250-fold selectivity for… |
5 mg |
17419-5 |
More Info
|
TCS-OX2-29 |
An antagonist of OX2R (pKi = 7.5) that exhibits >250-fold selectivity for… |
50 mg |
17419-50 |
More Info
|
TCS PIM-1 1 |
An ATP-competitive Pim-1 kinase inhibitor (IC50 = 50 nM) that displays sel… |
10 mg |
16286-10 |
More Info
|
TCS PIM-1 1 |
An ATP-competitive Pim-1 kinase inhibitor (IC50 = 50 nM) that displays sel… |
100 mg |
16286-100 |
More Info
|
TCS PIM-1 1 |
An ATP-competitive Pim-1 kinase inhibitor (IC50 = 50 nM) that displays sel… |
5 mg |
16286-5 |
More Info
|
TCS PIM-1 1 |
An ATP-competitive Pim-1 kinase inhibitor (IC50 = 50 nM) that displays sel… |
50 mg |
16286-50 |
More Info
|
TC 14012 (trifluoroacetate salt) |
A CXCR4 antagonist (IC50 = 2.9 nM) and CXCR7 agonist; induces β-arres… |
1 mg |
11974-1 |
More Info
|
TC 14012 (trifluoroacetate salt) |
A CXCR4 antagonist (IC50 = 2.9 nM) and CXCR7 agonist; induces β-arres… |
10 mg |
11974-10 |
More Info
|
TC 14012 (trifluoroacetate salt) |
A CXCR4 antagonist (IC50 = 2.9 nM) and CXCR7 agonist; induces β-arres… |
5 mg |
11974-5 |
More Info
|
tcY-NH2 (trifluoroacetate salt) |
A peptide antagonist of PAR4; inhibits platelet aggregation induced by AYP… |
1 mg |
36758-1 |
More Info
|
tcY-NH2 (trifluoroacetate salt) |
A peptide antagonist of PAR4; inhibits platelet aggregation induced by AYP… |
10 mg |
36758-10 |
More Info
|
tcY-NH2 (trifluoroacetate salt) |
A peptide antagonist of PAR4; inhibits platelet aggregation induced by AYP… |
5 mg |
36758-5 |
More Info
|
tcY-NH2 (trifluoroacetate salt) |
A peptide antagonist of PAR4; inhibits platelet aggregation induced by AYP… |
500 µg |
36758-500 |
More Info
|
TD-4208 |
An antagonist of muscarinic acetylcholine receptors (Kis = 0.42, 0.3, 0.18… |
10 mg |
36549-10 |
More Info
|
TD-4208 |
An antagonist of muscarinic acetylcholine receptors (Kis = 0.42, 0.3, 0.18… |
100 mg |
36549-100 |
More Info
|
TD-4208 |
An antagonist of muscarinic acetylcholine receptors (Kis = 0.42, 0.3, 0.18… |
25 mg |
36549-25 |
More Info
|
TD-4208 |
An antagonist of muscarinic acetylcholine receptors (Kis = 0.42, 0.3, 0.18… |
50 mg |
36549-50 |
More Info
|
TD52 |
A derivative of erlotinib; decreases the viability of HA22T, Hep3B, PLC /… |
10 mg |
37744-10 |
More Info
|
TD52 |
A derivative of erlotinib; decreases the viability of HA22T, Hep3B, PLC /… |
25 mg |
37744-25 |
More Info
|
TD52 |
A derivative of erlotinib; decreases the viability of HA22T, Hep3B, PLC /… |
5 mg |
37744-5 |
More Info
|
TD52 |
A derivative of erlotinib; decreases the viability of HA22T, Hep3B, PLC /… |
50 mg |
37744-50 |
More Info
|
TDFA (trifluoroacetate salt) |
A PAD4 inhibitor (IC50 = 2.3 µM); selective for PAD4 over PAD1, PAD2… |
1 mg |
22484-1 |
More Info
|